V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Mid
R
RCKTAI Stock Diagnostic Report

Rocket Pharma updates progress on RP-A501 for Danon disease

Rocket Pharmaceuticals has provided an update on the development progress of the Danon disease therapeutic RP-A501, but the specific impact on the stock price is judged to be limited.

View Source Article ↗
AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

RCKT Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-10-08 16:47:23RCKT65MidView Report →
2026-10-07 15:50:09RCKT50MidView Report →
2026-09-16 15:22:51RCKT80S-ClassView Report →
View Full History for RCKT (Blueprint) →